Nuclear neurotransmitter molecular imaging of autism spectrum disorder
Autism spectrum disorder (ASD) is a group of developmental disabilities characterized by marked deficits in social communication and interaction, including limited and repetitive patterns of behavior. We selected key nuclear neurotransmitter molecular imaging reports of ASD by combining “autism” AND...
Main Authors: | Alveena Batool Syed, James Robert Brašić |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2019-01-01
|
Series: | AIMS Molecular Science |
Subjects: | |
Online Access: | https://www.aimspress.com/article/10.3934/molsci.2019.4.87/fulltext.html |
Similar Items
-
Mapping dopamine with positron emission tomography: A note of caution
by: Alain Dagher, et al.
Published: (2020-02-01) -
A Review of Molecular Imaging of Glutamate Receptors
by: Jong-Hoon Kim, et al.
Published: (2020-10-01) -
Cognitive Function and Monoamine Neurotransmission in Schizophrenia: Evidence From Positron Emission Tomography Studies
by: Harumasa Takano
Published: (2018-05-01) -
Unilateral Thalamic Hypometabolism in Patients With Temporal Lobe Epilepsy
by: Cheng-Pei Chang, et al.
Published: (2008-07-01) -
Recent Advances in Radiotracer Imaging Hold Potential for Future Refined Evaluation of Epilepsy in Veterinary Neurology
by: Marion Bankstahl, et al.
Published: (2017-12-01)